{"id":"https://openalex.org/W4200599749","doi":"https://doi.org/10.1016/j.deman.2021.100038","title":"Utilisation and expenditure on glucose-lowering drugs used for the treatment of type 2 diabetes mellitus in Ireland, a repeated cross-sectional study","display_name":"Utilisation and expenditure on glucose-lowering drugs used for the treatment of type 2 diabetes mellitus in Ireland, a repeated cross-sectional study","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-11","ids":{"openalex":"https://openalex.org/W4200599749","doi":"https://doi.org/10.1016/j.deman.2021.100038"},"language":"en","primary_location":{"id":"doi:10.1016/j.deman.2021.100038","doi":"https://doi.org/10.1016/j.deman.2021.100038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.deman.2021.100038","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266697062100038X/pdf","source":{"id":"https://openalex.org/S4210215582","display_name":"Diabetes Epidemiology and Management","issn_l":"2666-9706","issn":["2666-9706"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Epidemiology and Management","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200599749"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S266697062100038X/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024100262","display_name":"Amelia Smith","orcid":"https://orcid.org/0000-0003-3070-2268","observed_orcids":["https://orcid.org/0000-0003-3070-2268"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I37076085","display_name":"Health Service Executive","ror":"https://ror.org/04zke5364","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2800263200","https://openalex.org/I37076085","https://openalex.org/I4210136517"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":true,"raw_author_name":"Amelia Smith","raw_affiliation_strings":["Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I205274468","https://openalex.org/I4210154619"]},{"raw_affiliation_string":"Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I37076085","https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002000655","display_name":"Carmel Kennedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Carmel Kennedy","raw_affiliation_strings":["Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I205274468","https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102793343","display_name":"Sarah Clarke","orcid":"https://orcid.org/0000-0003-3121-8427","observed_orcids":["https://orcid.org/0000-0003-3121-8427"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I37076085","display_name":"Health Service Executive","ror":"https://ror.org/04zke5364","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2800263200","https://openalex.org/I37076085","https://openalex.org/I4210136517"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Sarah Clarke","raw_affiliation_strings":["Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I205274468","https://openalex.org/I4210154619"]},{"raw_affiliation_string":"Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I37076085","https://openalex.org/I4210154619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031842368","display_name":"Michael G. Barry","orcid":"https://orcid.org/0000-0002-6232-3003","observed_orcids":["https://orcid.org/0000-0002-6232-3003"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I37076085","display_name":"Health Service Executive","ror":"https://ror.org/04zke5364","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2800263200","https://openalex.org/I37076085","https://openalex.org/I4210136517"]},{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Michael Barry","raw_affiliation_strings":["Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I205274468","https://openalex.org/I4210154619"]},{"raw_affiliation_string":"Medicines Management Programme, Health Services Executive (HSE), Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland","institution_ids":["https://openalex.org/I37076085","https://openalex.org/I4210154619"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024100262"],"corresponding_institution_ids":["https://openalex.org/I205274468","https://openalex.org/I37076085","https://openalex.org/I4210154619"],"apc_list":{"value":2280,"currency":"USD","value_usd":2280},"apc_paid":{"value":2280,"currency":"USD","value_usd":2280},"fwci":0.3058,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.49811736,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":94},"biblio":{"volume":"5","issue":null,"first_page":"100038","last_page":"100038"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9589999914169312},{"id":"https://openalex.org/keywords/drug-utilisation","display_name":"drug utilisation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pharmaceutical-expenditure","display_name":"pharmaceutical expenditure","score":0.6899999976158142},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9909999966621399},{"id":"https://openalex.org/keywords/prescribing-rates","display_name":"prescription rates","score":0.675000011920929},{"id":"https://openalex.org/keywords/pharmacy-claims-data","display_name":"pharmacy claims data","score":0.6669999957084656},{"id":"https://openalex.org/keywords/economic-burden-of-diabetes","display_name":"economic burden of diabetes","score":0.7570000290870667},{"id":"https://openalex.org/keywords/ireland","display_name":"Ireland","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8324947357177734},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5980939865112305},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5875558257102966},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5661278963088989},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5367788672447205},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5184516310691833},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5170264840126038},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.4568946361541748},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.45136499404907227},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.40640777349472046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33924591541290283},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2574957013130188},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21839332580566406},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.13957655429840088},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.10271689295768738},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.deman.2021.100038","doi":"https://doi.org/10.1016/j.deman.2021.100038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.deman.2021.100038","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266697062100038X/pdf","source":{"id":"https://openalex.org/S4210215582","display_name":"Diabetes Epidemiology and Management","issn_l":"2666-9706","issn":["2666-9706"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Epidemiology and Management","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:4981f100a03b49118a3d792379b2a1be","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4981f100a03b49118a3d792379b2a1be","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Epidemiology and Management, Vol 5, Iss , Pp 100038- (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.deman.2021.100038","doi":"https://doi.org/10.1016/j.deman.2021.100038","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.deman.2021.100038","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266697062100038X/pdf","source":{"id":"https://openalex.org/S4210215582","display_name":"Diabetes Epidemiology and Management","issn_l":"2666-9706","issn":["2666-9706"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Epidemiology and Management","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200599749.pdf","grobid_xml":"https://content.openalex.org/works/W4200599749.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1554672086","https://openalex.org/W1577783343","https://openalex.org/W2127679612","https://openalex.org/W2147663252","https://openalex.org/W2234425174","https://openalex.org/W2515822454","https://openalex.org/W2519510391","https://openalex.org/W2530634871","https://openalex.org/W2534221266","https://openalex.org/W2570655515","https://openalex.org/W2605549377","https://openalex.org/W2606281213","https://openalex.org/W2610919116","https://openalex.org/W2754041380","https://openalex.org/W2801742794","https://openalex.org/W2802498945","https://openalex.org/W2884466498","https://openalex.org/W2884713629","https://openalex.org/W2894993577","https://openalex.org/W2900149048","https://openalex.org/W2974098728","https://openalex.org/W2979965402","https://openalex.org/W2983229458","https://openalex.org/W3009151641","https://openalex.org/W3082389140","https://openalex.org/W3086961619","https://openalex.org/W3092478144","https://openalex.org/W3120821309","https://openalex.org/W4206445899","https://openalex.org/W4247046340","https://openalex.org/W6686504550","https://openalex.org/W6736263832"],"related_works":["https://openalex.org/W4311495621","https://openalex.org/W2899963016","https://openalex.org/W4402137047","https://openalex.org/W4410232624","https://openalex.org/W2971541610","https://openalex.org/W2108472697","https://openalex.org/W2792145500","https://openalex.org/W3092478144","https://openalex.org/W2971173637"],"abstract_inverted_index":{"To":[0],"provide":[1],"an":[2,91,154,205],"update":[3],"on":[4,9,44],"the":[5,14,31,51,61,73,81,94,100,183,195,202,221],"utilisation":[6,95,131,150,196],"and":[7,65,80,115,178,208],"expenditure":[8,75,157],"glucose-lowering":[10,47,71,78,97,149],"drugs":[11,48],"used":[12,49],"for":[13,50,133],"treatment":[15,52,189],"of":[16,26,41,53,63,67,83,96,185,197,204,211],"type":[17,54,186,212],"2":[18,55,187,213],"diabetes":[19,56,188],"in":[20,34,93,113,125,130,136,148,153,156,161,166,190,194,201],"Ireland":[21],"a":[22,70,216],"repeated":[23],"cross-sectional":[24],"study":[25,36,101,169],"national":[27],"pharmacy":[28],"claims":[29],"data.":[30],"data":[32,43],"included":[33],"this":[35],"are":[37,181],"nationally":[38],"representative":[39],"(Republic":[40],"Ireland).":[42],"persons":[45],"receiving":[46,69],"were":[57,132,139],"included.":[58],"We":[59],"identified;":[60],"number":[62,66],"prescriptions":[64],"patients":[68,112,124],"agent,":[72],"total":[74],"associated":[76],"with":[77,103],"agents,":[79,200],"rate":[82],"prescribing":[84],"per":[85],"1,000":[86],"population.":[87],"There":[88],"has":[89,151],"been":[90],"increase":[92,147,155,193],"agents":[98,173],"over":[99,104,116],"period,":[102],"1.5":[105],"million":[106,118,160,165],"items":[107,119,141],"being":[108,120],"dispensed":[109,121,142],"to":[110,122,143,163,220],"105,236":[111],"2012":[114,162],"2.1":[117],"145,116":[123],"2019.":[126,167],"The":[127,192],"largest":[128],"increases":[129],"SGLT-2":[134,179],"inhibitors;":[135],"2019":[137],"there":[138],"205,659":[140],"23,074":[144],"patients.":[145],"This":[146,168],"resulted":[152],"from":[158],"\u20ac29.7":[159],"\u20ac57":[164],"shows":[170],"that":[171],"newer":[172],"(DPP-4":[174],"inhibitors,":[175],"GLP-1":[176],"analogues,":[177],"inhibitors)":[180],"changing":[182],"landscape":[184],"Ireland.":[191],"higher-cost":[198],"novel":[199],"context":[203],"ageing":[206],"population":[207],"increased":[209],"incidence":[210],"diabetes,":[214],"poses":[215],"significant":[217],"economic":[218],"burden":[219],"state":[222],"going":[223],"forward.":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200599749","counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2021-12-31T00:00:00"}
